Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE (Tables)

v3.23.2
EARNINGS PER SHARE (Tables)
 6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
SCHEDULE OF ANTI DILUTIVE SECURITIES

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive based on the application of the treasury stock method and because the Company incurred net losses during the period:

 SCHEDULE OF ANTI DILUTIVE SECURITIES

                         
    For the Six Months Ended June 30,     For the Three Months Ended June 30,  
    2023     2022     2023     2022  
Convertible notes payable     18,194,940       6,644,940       18,194,940       6,644,940  
Restricted stock units     343,512       -       171,756       11,840,890  
Warrants to purchase shares
of common stock		     -       8,432,288       -       11,840,890  
Total potentially dilutive shares     18,538,452       15,077,228       18,366,696       18,485,830  
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income per share:

 SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE

                         
    Six Months Ended June 30,     Three Months Ended June 30,  
    2023     2022     2023     2022  
                         
Net loss attributable to the common stockholders   $ (2,064,160 )   $ (1,344,371 )   $ (723,124 )   $ (666,325 )
                                 
Basic weighted average outstanding shares of common stock     40,911,801       37,295,813       43,331,086       37,295,813  
Dilutive effect of options and warrants     -       -       -       -  
Diluted weighted average common stock and common stock equivalents     40,911,801       37,295,813       43,331,086       37,295,813  
                                 
Loss per share:                                
Basic and diluted   $ (0.05 )   $ (0.04 )   $ (0.02 )   $ (0.02 )